Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
Diabetes Care - United States
doi 10.2337/dc18-1091
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2018
Authors
Publisher
American Diabetes Association